Skip to main content

Peer Review reports

From: Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter “real life” study

Original Submission
13 Jan 2017 Submitted Original manuscript
7 Feb 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 2
7 Feb 2017 Submitted Manuscript version 2
1 May 2017 Reviewed Reviewer Report - David F Jarrard
25 Jun 2017 Reviewed Reviewer Report - Klaus Brasso
13 Jul 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 3
13 Jul 2017 Submitted Manuscript version 3
18 Jul 2017 Reviewed Reviewer Report - Klaus Brasso
8 Aug 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 4
8 Aug 2017 Submitted Manuscript version 4
14 Sep 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 5
14 Sep 2017 Submitted Manuscript version 5
6 Oct 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 6
6 Oct 2017 Submitted Manuscript version 6
30 Oct 2017 Author responded Author comments - Luca Cindolo
Resubmission - Version 7
30 Oct 2017 Submitted Manuscript version 7
Publishing
6 Nov 2017 Editorially accepted
10 Nov 2017 Article published 10.1186/s12885-017-3755-x

You can find further information about peer review here.

Back to article page